MRI-based Body Composition Reimagined: Building a New Foundation for Treatment Differentiation Beyond Weight Loss
Time: 12:00 pm
day: Conference Day One
Details:
- FDA-cleared MRI-based body composition analysis provides a new standard for muscle and fat quantification enabling translation from population studies and clinical trials all the way into healthcare.
- Studies on Personalized Fat and Muscle Z-score biomarkers show improved prediction of outcomes and that weight- and BMI-invariant treatment effects can be detected.
- Exploring the varying effects of the GLP-1 agonists liraglutide and tirzepatide on muscle and fat measurements in recent clinical trials.
